Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.14
-0.09-7.32%
Last update: Oct 16, 6:33 PM
$1.14
-0.09-7.32%
Purple Biotech Ltd (PPBT) Stock Price, Quote, News & History
PPBTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Purple Biotech (NASDAQ:PPBT) through any online brokerage.
Other companies in Purple Biotech’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Purple Biotech has a consensus price target of $1108.50.
The stock price for Purple Biotech (NASDAQ: PPBT) is $1.14 last updated October 16, 2026 at 6:33 PM EDT.
There are no upcoming dividends for Purple Biotech.
Purple Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Purple Biotech.
Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
